Elizabeth A. Grammer

CIK: 0001213041

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (62.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SGMT

Sagimet Biosciences Inc.

Director

ARDX

ARDELYX, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

SGMT
Sagimet Biosciences Inc.
Jun 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
39.6K shares-
ARDX
ARDELYX, INC.
Nov 21, 2025
Sale(S)
Direct
6K shares at avg. $5.54$33K
ARDX
ARDELYX, INC.
Aug 21, 2025
Sale(S)
Direct
5.8K shares at avg. $5.93$35K
SGMT
Sagimet Biosciences Inc.
Jun 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
32.3K shares-
ARDX
ARDELYX, INC.
May 20, 2025
Sale(S)
Direct
6K shares at avg. $4.08$24K
ARDX
ARDELYX, INC.
Feb 25, 2025
Award(A)
Direct
136.7K shares-
ARDX
ARDELYX, INC.
Feb 20, 2025
Sale(S)
Direct
4.3K shares at avg. $5.62$24K
ARDX
ARDELYX, INC.
Nov 20, 2024
Sale(S)
Direct
7K shares at avg. $4.79$34K

		Type	Shares	Price		Ownership
Jun 12, 2026	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	39,567	-	-	Direct
Nov 21, 2025	ARDX ARDELYX, INC.	Sale(S)	5,995	$5.54	$33,194	Direct
Aug 21, 2025	ARDX ARDELYX, INC.	Sale(S)	5,841	$5.93	$34,647	Direct
Jun 9, 2025	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	32,250	-	-	Direct
May 20, 2025	ARDX ARDELYX, INC.	Sale(S)	5,992	$4.08	$24,456	Direct
Feb 25, 2025	ARDX ARDELYX, INC.	Award(A)	136,680	-	-	Direct
Feb 20, 2025	ARDX ARDELYX, INC.	Sale(S)	4,291	$5.62	$24,128	Direct
Nov 20, 2024	ARDX ARDELYX, INC.	Sale(S)	7,046	$4.79	$33,782	Direct

1-8 of 8 transactions

About GRAMMER ELIZABETH A

GRAMMER ELIZABETH A (SEC CIK 0001213041) files insider reports with the SEC as Director of Sagimet Biosciences Inc. (SGMT) and Officer of ARDELYX, INC. (ARDX).

Signal8 holds 8 ownership filings by GRAMMER ELIZABETH A, all Form 4s, filed between Nov 22, 2024 and Jun 15, 2026. Those filings report 8 transactions, from Nov 20, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GRAMMER ELIZABETH A's filings is in SAN MATEO, CA.

Recent filings by GRAMMER ELIZABETH A

Jun 12, 2026: Grant or award of SGMT derivative securities (Form 4, code A).
Nov 21, 2025: Open-market sale of ARDX shares (Form 4, code S).
Aug 21, 2025: Open-market sale of ARDX shares (Form 4, code S).
Jun 9, 2025: Grant or award of SGMT derivative securities (Form 4, code A).
May 20, 2025: Open-market sale of ARDX shares (Form 4, code S).

Other insiders filing for Sagimet Biosciences Inc. (SGMT)

Kemble George, Director
Happel David, President & CEO
Rozek Elizabeth, Chief Legal & Admin. Officer
SEIDENBERG BETH C, Director
Hoelscher Paul W., Director
Jarrett Jennifer, Director

How to read Form 4 transaction codes